Pioglitazone treatment reduces adipose tissue inflammation through reduction of mast cell and macrophage number and by improving vascularity.

by Michael Spencer, Lin Yang, Akosua Adu, Brian S Finlin, Beibei Zhu, Lindsey R Shipp, Neda Rasouli, Charlotte A Peterson, Philip A Kern
Published 2014-01-01

The Influence of a KDT501, a Novel Isohumulone, on Adipocyte Function in Humans

by Brian S. Finlin, Beibei Zhu, Bernard P. Kok, Cristina Godio, Philip M. Westgate, Neile Grayson, Robert Sims, Jeffrey S. Bland, Enrique Saez, Philip A. Kern
Published 2017-09-01

Pioglitazone does not synergize with mirabegron to increase beige fat or further improve glucose metabolism

by Brian S. Finlin, Hasiyet Memetimin, Beibei Zhu, Amy L. Confides, Hemendra J. Vekaria, Riham H. El Khouli, Zachary R. Johnson, Philip M. Westgate, Jianzhong Chen, Andrew J. Morris, Patrick G. Sullivan, Esther E. Dupont-Versteegden, Philip A. Kern
Published 2021-03-01